AI assistant
STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2025
Jan 23, 2025
62616_rns_2025-01-23_417503a1-9e1e-4ef8-8454-62d6cddbe556.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [145 x 47] intentionally omitted <==
January 23, 2025
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
Scrip code: 532531
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051
Scrip code: STAR
Dear Madam/ Sirs,
- Sub: OneSource Specialty Pharma Limited (OneSource) - India’s first Specialty Pharma CDMO receives Listing and Trading approval for its Equity Shares from BSE and NSE.
OneSource to start trading in NSE and BSE from January 24, 2025
We wish to inform you that OneSource has received Final Listing and Trading approval for its Equity Shares from the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on Wednesday, January 22, 2025 .
Scrip Code of OneSource is as under:
-
NSE: ONESOURCE
-
BSE: 544292
OneSource shall start trading on NSE and BSE from Friday, January 24, 2025 onwards.
You are kindly requested to take the same on record.
Thanks & Regards, For Strides Pharma Science Limited,
MANJULA R
Digitally signed by MANJULA R Date: 2025.01.23 10:57:28 +05'30'
Manjula Ramamurthy Company Secretary ICSI Membership No. A30515
==> picture [479 x 50] intentionally omitted <==